Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0RLP
|
||||
| Drug Name |
4-{[4-(Ethyloxy)phenyl]methyl}-2-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767139
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H27N3O2
|
||||
| Canonical SMILES |
CCOc1ccc(CC2=NN(C[C@H]3CCCN3C)C(=O)c4ccccc24)cc1
|
||||
| InChI |
InChI=1S/C23H27N3O2/c1-3-28-19-12-10-17(11-13-19)15-22-20-8-4-5-9-21(20)23(27)26(24-22)16-18-7-6-14-25(18)2/h4-5,8-13,18H,3,6-7,14-16H2,1-2H3/t18-/m1/s1
|
||||
| InChIKey |
URSKGEZFWCRYMD-GOSISDBHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.